Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 2OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Renal Cell 30Neoplasms 11Sarcoma 8Carcinoma, Non-Small-Cell Lung 8Breast Neoplasms 7Ovarian Neoplasms 6Neoplasm Metastasis 5Fallopian Tube Neoplasms 3Colorectal Neoplasms 3Recurrence 2Hemangiosarcoma 2Financial Stress 2Clear-cell metastatic renal cell carcinoma 2Carcinoma, Ovarian Epithelial 2Uterine Diseases 1Uterine Cervical Neoplasms 1Uterine Cervical Diseases 1Solid Tumours 1Solid Tumors 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Prostatic Neoplasms 1Patient Preference 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Osteosarcoma 1Neoplasms, Plasma Cell 1Melanoma 1Liver Neoplasms 1Leiomyosarcoma 1

Interventions

Cyclophosphamide 6tazemetostat 5fludarabine 4pembrolizumab 2soblidotin 1reolysin 1pazopanib 1drozitumab 1cixutumumab 1atezolizumab 1anlotinib 1Tablets 1Rosuvastatin Calcium 1Rifampin 1Ramucirumab 1Radiation 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Midazolam 1Itraconazole 1Injections 1Immunotherapy, Adoptive 1Immunotherapy 1Imatinib Mesylate 1Ifosfamide 1Gemcitabine 1Drug Therapy 1Doxorubicin 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Sarcoma, Synovial × pazopanib × Clear all
NCT00297258 2016-02-03

Pazopanib In Patients With Relapsed Or Refractory Soft Tissue Sarcoma

GlaxoSmithKline

Phase 2 Completed
148 enrolled 8 charts
Sarcoma

Leiomyosarcoma, Sarcoma, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡